Effect of short term recombinant human erythropoietin (rHuEPO) therapy in the prevention of anemia of prematurity (AOP) in very low birth weight (VLBW) neonates

Bangladesh Medical Research Council Bulletin

Volumn 38, Issue 3, 2012, Pages 119-123

  Yasmeen, B H N ^a   Chowdhury, M A K A ^b   Hoque, M M ^b   Hossain, M M ^b   Jahan, R ^b   Akhtar, S ^c  

^a Northern International Medical College   (Bangladesh)

^b DHAKA SHISHU HOSPITAL   (Bangladesh)

^c Enam medical college   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ANEMIA OF PREMATURITY; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; FOLLOW UP; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VERY LOW BIRTH WEIGHT;

EID: 84876943802     PISSN: 03779238     EISSN: None     Source Type: Journal    
DOI: 10.3329/bmrcb.v38i3.14340     Document Type: Article

References (19)

1. George Cassady, Anaemia of prematurity, emedicine Jan 15, 2009 (Updated: Dec 8, 2011) at (http://emedicine.medscape.com/article978238- overview)
2. Widness JA. Pathophysiology, diagnosis and prevention of neonatal anaemia. Padiatrics in Reviews, Neo Reviews 2000; 7: 861-68.
3. Maier RF, Obladen M, Scigalla P. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very low birth weight infants. N Engl J Med 1994; 330: 1173-78.
4. Ohls RK. The use of erythropoietin in neonates. Clinics in Perinatology 2000; 27: 681-96.
5. Bechensteen AG, Haga P, Halvorsen S. Erythropoietin, protein and iron supplementation and the prevention of he anaemia of prematurity. Archives of Disease in Childhood 1993; 69: 645-53.
6. Garcia MG, Hutson AD, Christensen RD. Effect of recombinant erythropoietin on late transfusions in the neonatal intensive care unit: a meta analysis. Journal of Perinatology 2002; 22: 108-11.
7. Maier RF, Obladen M, Mullrer HI. Early treatment with erythropoietin beta ameliorates anaemia and reduces transfusion requirements in infants with birth weights below 1000g. Journal of pediatrics. 2002; 141: 8-15.
8. Meyer MP, Sharma E, Carsons M. Recombinant erythropoietin and blood transfusion in selected preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2003; 88: 41-45.
9. Halpérin DS, Wacker P, Lacourt G. Effects of recombinant human erythropoietin in infants with the anaemia of prematurity: a pilot study. J Pediatr 1990; 116: 779-86
10. Ohls RK, Christensen RD. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anaemia of prematurity. J Pediatr 1991; 119:781-88.
11. Shannon KM, Keith JF, Mentzer WC. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995; 95: 1-8.
12. Gomella TL, Couningham MD, Eyal FG, Zenk KE. Blood Abnormalities. In: Neonatology: Management procedures, oncall problems, disease and drugs, 5thed. USA: Mc Graw Hill Companies; 2004: 334-341.
13. Halperin DS. Use of recombinant erythropoietin in treatment of the anaemia of prematurity. Am J Pediatr Hematol Oncol 1991; 13: 351-63.
14. Stockman III JA, Graeber JE, Clark BA. Anaemia of prematurity: determinant of the erythropoietin response. J Pediatr 1984; 105: 786-92.
15. Donato 11, Vain N, Rendo P et al, Effect of Early versus Late Recombinant Human Erythropoietin on Transfusion Requirements in Premature Infants results of A Randomized, Placebo-controlled, Multicenter Trial. PEDIATRICS 2000; 105(5): 1066-72.
16. Eschbach JW, Egrie JC, Downing MR. Correction of the Anaemia of End Stage Renal Disease with Recombinant Human Erythropoietin. N Engl J Med. 1987; 316: 73-8.
17. Eschbach JW, Abdul Hadi MH, Browne JK. Recombinant Human Erythropoietin in anaemic patient with End Stage Renal Disease. Ann Intern Med 1989, 111: 992-1000.
18. Ohls RK, Osborne KA, Christensen RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo controlled trial. J Pediatr 1995; 126: 421-6.
19. Meyer MP, Meyer JH, Commerford A. Recombinant human erythropoietin in the treatment of the anaemia of prematurity: results of a double-blind, placebocontrolled study. Pediatrics 1994; 93(9): 18-23.